Immunophage Biotech Raises RMB 200 Million in Series B1 Financing for Clinical Trials
Nanjing-based Immunophage Biotech Co., Ltd reportedly raised close to RMB 200 million (USD 29.1 million)...
Akeso Biopharma Enrolls First Subject in Phase III Study of Cadonilimab for Gastric Cancer
China-based Akeso Biopharma (HKG: 9926) has announced the enrollment of the first subject in a...
CSPC Pharmaceutical’s PD-1 Monoclonal Antibody Enlangsubai Completes NMPA Market Approval Filing
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced the completion of a market approval...
Pasteur Institute Suspends Joint Venture with Chinese Academy of Sciences
France’s Pasteur Institute has announced its decision to suspend its joint-venture (JV) partnership with the...
Boston Scientific Launches REPLACE Study for FARAPULSE PFA System in China
US-based medical technology major Boston Scientific Corporation (NYSE: BSX) has announced the initiation of the...
Chipscreen’s Epidaza Receives TFDA Approval for Breast Cancer Treatment in Taiwan
Shenzhen Chipscreen Pharmaceutical Co., Ltd’s partner, GNT Biotech & Medicals Corporation, has announced that it...
Silicon Valley Bank Collapse Impacts Tech and Biotech Sectors Globally
The tech and biotech sectors are grappling with the implications of the collapse of US-based...
Allorion Therapeutics Raises USD 50 Million in Series B Financing to Advance Drug Development
Allorion Therapeutics, a next-generation precision medicine small molecule drug developer based in Guangzhou, reportedly raised...
XtalPi and Chia Tai Tianqing Achieve Phase II Milestone in Cancer Drug Development
Sino-US artificial intelligence (AI) firm XtalPi Inc. has partnered with China’s Chia Tai Tianqing to...
Overland Pharmaceuticals Partners with GoBroad Healthcare to Strengthen Cell Therapy Research
China-based firm Overland Pharmaceuticals has entered into a strategic partnership with GoBroad Healthcare Group to...
Haihe Pharmaceutical Initiates Global Phase I Clinical Study for BET-BD2 Inhibitor HH3806
Shanghai Haihe Pharmaceutical Co., Ltd has announced the first patient dosing of a global multi-center...
CanSino Biologics Initiates Phase Ib Study for Innovative Protein-Based Pneumococcal Vaccine
China-based vaccines specialist CanSino Biologics Inc. has announced the initiation and first subject enrollment of...
Zenshine Pharmaceuticals Raises RMB 100 Million in Series B Financing for Drug Development
China-based small molecule drug developer Nanjing Zenshine Pharmaceuticals Co., Ltd reportedly raised over RMB 100...
Livzon Pharmaceutical Secures Exclusive Rights to Onconic’s GERD Treatment Zastaprazan
China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has announced a licensing agreement with South Korean...
CStone’s Ayvakit Shows Significant Improvements in ISM at AAAAI Meeting
China-based CStone Pharmaceuticals (HKG: 2616) announced that its US partner, Blueprint Medicines, published detailed data...
Lifetech’s IBS Angel Stent System Gains EU CE MDR Certification
China-based Lifetech Scientific Corporation (HKG: 1302) has announced that it has received CE MDR certification...
Olipharma Secures Funding for Manufacturing Expansion in Pre-Series A+ Round
Olipharma, a Contract Development and Manufacturing Organization (CDMO) specializing in small nucleic acid drugs and...
Inventiva and Chia Tai Tianqing’s Lanifibranor Advances with CDE Filing
France-based Inventiva S.A. and China’s Chia Tai Tianqing have successfully filed a clinical trial application...
Simcere’s SIM0237 Begins Clinical Study for PD-L1 and IL-15 Targeting Bispecific Antibody
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced the first patient in (FPI) a clinical...
AusperBio and Asymchem Form Strategic Partnership for Drug Development
China-based firms AusperBio and Asymchem (SHE: 002821, HKG: 6821) have entered into a strategic partnership...